Cost and Benefit Estimates

Sardar M. N. Islam and Christine Suet Yee Mak
Additional contact information
Sardar M. N. Islam: Victoria University
Christine Suet Yee Mak: Victoria University

Chapter 5 in Normative Health Economics, 2006, pp 101-132 from Palgrave Macmillan

Abstract: Abstract In this chapter, we discuss the general principles and methods of estimating costs and benefits of six medications (namely Atorvastatin, Clopidogrel, Pioglitazone, Letrozole, Fluticasone/ Salmeterol and Tiotropium) while the detailed estimates of the costs and benefits and their analysis will be provided in the next chapter.

Keywords: Chronic Obstructive Pulmonary Disease; Medical Practitioner; Complementary Medicine; National Health Survey; General Medical Practitioner (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-28905-5_5

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230289055

DOI: 10.1057/9780230289055_5

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().